Minimal residual disease in acute myeloid leukaemia
- 1 March 2002
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 15 (1) , 119-135
- https://doi.org/10.1053/beha.2002.0188
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Improved Sensitivity of BCR-ABL Detection: A Triple-Probe Three-Color Fluorescence In Situ Hybridization SystemBlood, 1997
- Detection of 16 p deletions by FISH in patients with inv(16) or t(16;16) and acute myeloid leukemia (AML)Leukemia, 1997
- Application of fluorescence in situ hybridization to detect residual leukemic cells with 9;22 and 15;17 translocationsLeukemia, 1997
- Clonality analysis of hematopoietic cell lineages in acute myeloid leukemia and translocation (8;21): only myeloid cells are part of the malignant cloneLeukemia, 1997
- Detecting genetic changes in human tumor cells: have scientists "gone fishing?" [editorial] [see comments]Blood, 1993
- Minimal residual disease in acute leukaemia: preclinical studies in a relevant rat model (BNML)Bailliere's Clinical Haematology, 1991
- Detection of bcr - abl Fusion in Chronic Myelogeneous Leukemia by in Situ HybridizationScience, 1990
- Nonhomogeneous distribution of leukemia in the bone marrow during minimal residual diseaseBlood, 1987
- DISCREPANT BONE-MARROW ASPIRATIONS IN LEUKÆMIAThe Lancet, 1977
- Cytogenetic Studies and Their Clinical Correlates in Adults with Acute LeukemiaAnnals of Internal Medicine, 1971